"Founded in 1938, St. Mary’s Medical Center is a 460-bed, acute care hospital that provides medical, surgical, obstetrical, pediatric, trauma and emergency services to a five-county area. What started as a small 50-bed facility founded by the Franciscan Sisters of Allegany, has grown into a dynamic institution, known for its innovation and award-winning programs, as well as a legacy of excellence that began more than three generations ago."

During the past decade, Kaplan Cancer Center at St. Mary's Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaplan Cancer Center at St. Mary's Medical Center" #1 sponsor was "Children's Oncology Group" with 36 trials, followed by "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "SWOG Cancer Research Network" with 1 trials sponsored and "University of Leicester" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaplan Cancer Center at St. Mary's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Kaplan Cancer Center at St. Mary's Medical Center" are "Leukemia" (11 trials), "Sarcoma" (8 trials), "Lymphoma" (6 trials), "Brain Tumor" (5 trials) and "Neuroblastoma" (5 trials). Many other conditions were trialed in "Kaplan Cancer Center at St. Mary's Medical Center" in a lesser frequency.

Most popular intervention types in "Kaplan Cancer Center at St. Mary's Medical Center" are "Drug" (34 trials), "Biological" (18 trials), "Procedure" (17 trials), "Radiation" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (17 trials), "cyclophosphamide" (14 trials), "filgrastim" (14 trials), "vincristine sulfate" (13 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Kaplan Cancer Center at St. Mary's Medical Center" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Kaplan Cancer Center at St. Mary's Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Kaplan Cancer Center at St. Mary's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaplan Cancer Center at St. Mary's Medical Center, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".